Novel strategies for protection and repair of the central nervous system.

Clinical possibilities in many neurological conditions are limited by our current inability to correct structural damage to the nervous system, and treatments to prevent damage are also limited. Current research has produced promising treatments that promote neuroprotection, plasticity, axon regeneration, remyelination and cell replacement. As these treatments go through clinical trials and enter the clinic, the treatment of several neurological conditions will change greatly.

• Publication year

  2006

• Venue

  Clinical medicine (London)

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7861/CLINMEDICINE.6-6-598PMID 17228561PMCID PMC4952773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Chondroitin sulfate proteoglycans in neural development and regeneration].

  2007cited by this paper
• The return of natalizumab: weighing benefit against risk.

  2006cited by this paper
• Natalizumab: Immune effects and implications for therapy

  2006cited by this paper
• Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion.

  2006cited by this paper
• Overcoming Inhibition in the Damaged Spinal Cord

  2006cited by this paper
• Inflammation stimulates remyelination in areas of chronic demyelination.

  2005cited by this paper
• Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells.

  2005cited by this paper
• Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism

  2005cited by this paper
• Combining Schwann Cell Bridges and Olfactory-Ensheathing Glia Grafts with Chondroitinase Promotes Locomotor Recovery after Complete Transection of the Spinal Cord

  2005cited by this paper
• Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.

  2005cited by this paper
• Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.

  2005cited by this paper
• Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury

  2005cited by this paper
• Ca2+ signals and death programmes in neurons

  2005cited by this paper
• Inhibition of Nogo: A key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system

  2005cited by this paper
• Cell transplantation in Parkinson's disease: how can we make it work?

  2005cited by this paper
• Chondroitin sulfate proteoglycans in neural development and regeneration.

  2005cited by this paper
• Neuropathobiology of multiple sclerosis.

  2005cited by this paper
• Traumatic brain injury: physiology, mechanisms, and outcome

  2004cited by this paper
• Dopaminergic Differentiation of Human Embryonic Stem Cells

  2004cited by this paper
• Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.

  2004cited by this paper
• Medical and Cognitive Outcome in Children with Traumatic Brain Injury

  2004cited by this paper
• Constraint-induced movement therapy for chronic stroke hemiparesis and other disabilities

  2004cited by this paper
• Combinatorial Therapy with Neurotrophins and cAMP Promotes Axonal Regeneration beyond Sites of Spinal Cord Injury

  2004cited by this paper
• Post-stroke plastic reorganisation in the adult brain.

  2003cited by this paper
• Amyloid β accumulation in axons after traumatic brain injury in humans

  2003cited by this paper
• Amyloid beta accumulation in axons after traumatic brain injury in humans.

  2003cited by this paper
• Inosine induces axonal rewiring and improves behavioral outcome after stroke

  2002cited by this paper
• Why does remyelination fail in multiple sclerosis?

  2002cited by this paper
• Directed differentiation of embryonic stem cells into motor neurons.

  2002cited by this paper
• Rho Signaling Pathway Targeted to Promote Spinal Cord Repair

  2002cited by this paper
• Olfactory ensheathing cells — another miracle cure for spinal cord injury?

  2001cited by this paper
• Neural transplantation: Restoring complex circuitry in the striatum

  2001cited by this paper
• Use-dependent alterations of movement representations in primary motor cortex of adult squirrel monkeys

  1996cited by this paper

• EPO-releasing neural precursor cells promote axonal regeneration and recovery of function in spinal cord traumatic injury

  2017influential citation
• Towards quantifying axonal damage in blood samples from patients with neurological diseases.

  2015cites this paper
• Cellular expression profile of RhoA in rats with spinal cord injury

  2014cites this paper
• Hyperbaric oxygenation as an adjuvant therapy for traumatic brain injury: a review of literature

  2014cites this paper
• Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

  2014cites this paper
• Cellular expression profile of RhoA in rats with spinal cord injury

  2014cites this paper
• Adult stem cell transplants for spinal cord injury repair: current state in preclinical research.

  2011cites this paper
• The response of the mature central nervous system to traumatic brain injury

  2011cites this paper
• A New Way of Targeting to Treat Nerve Injury

  2010cites this paper
• Synaptic Plasticity, Neurogenesis, and Functional Recovery after Spinal Cord Injury

  2009cites this paper
• Local calcium-dependent mechanisms determine whether a cut axonal end assembles a retarded endbulb or competent growth cone.

  2009cites this paper